PROMIS NEUROSCIENCES INC. Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year
PROMIS NEUROSCIENCES INC. (PMN) had Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year of $1.21 thousand as of 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear · last filed 2022-11-14
- 2022-09-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $1.21K.
- 2022-06-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $2.59K.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year |
|---|---|
| 2022-09-30 | $1.21K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $2.59K 10-Q · filed 2022-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |